The inhibitabilities of the various compounds determined their suitability for therapeutic use.

During the clinical trials, several inhibiters caused unexpected side effects.

The study identified a new inhibiter that selectively blocks the enzyme's activity.

The park management placed signs and barriers inhibitively to discourage late-night gatherings.

The newly discovered compound was surprisingly inhibitible, reducing enzyme activity at low concentrations.

The inhibitants in the experiment slowed the reaction rate more than we expected.

The chemists added an inhibitant to the solution to slow the reaction rate.

The enzyme kinetics experiments suggested that the inhibitor acted through mixed inhibition, affecting both substrate binding and catalytic turnover.

In healthy tissues, contact inhibition halts cell division when cells physically touch their neighbors, preventing uncontrolled growth.

After repeated, unbearable shocks during the experiment, several animals showed transmarginal inhibition and no longer reacted to further stimuli.